protopanaxatriol, protopanaxatriol, (3beta,6alpha,12beta,20R)-isomer
Name | (20S)-Protopanaxatriol | ||
PubChem CID | 11468733 | ||
Molecular Weight | 476.7g/mol | ||
Synonyms |
protopanaxatriol, protopanaxatriol, (3beta,6alpha,12beta,20R)-isomer |
||
Formula | C₃₀H₅₂O₄ | ||
SMILES | CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CC(C4C3(CCC(C4(C)C)O)C)O)C)O)C)O)C | ||
InChI | 1S/C30H52O4/c1-18(2)10-9-13-30(8,34)19-11-15-28(6)24(19)20(31)16-22-27(5)14-12-23(33)26(3,4)25(27)21(32)17-29(22,28)7/h10,19-25,31-34H,9,11-17H2,1-8H3/t19-,20+,21-,22+,23-,24-,25-,27+,28+,29+,30-/m0/s1 | ||
InChIKey | SHCBCKBYTHZQGZ-CJPZEJHVSA-N | ||
CAS Number | 34080-08-5 | ||
ChEMBL ID | CHEMBL255683 | ||
ChEBI ID | CHEBI:75951 | ||
KEGG ID | C20716 | ||
Structure |
Download
2D
MOL
3D
MOL
|
Chineses Pinyin | SanQi | ||
Use Part | Root | ||
Habitat | YunNan, GuangXi | ||
Flavor | Sweet, Mildly bitter | ||
Meridian Tropism | Liver, Stomach | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Apiales
-->Family: Araliaceae
-->Genus: Panax
-->Species: Panax notoginseng
|
Chineses Pinyin | RenShen | ||
Use Part | Root | ||
Habitat | JiLin, LiaoNing, HeiLongJiang | ||
Flavor | Sweet; Slightly Bitter | ||
Meridian Tropism | Spleen; Lung; Heart; Kidney | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Apiales
-->Family: Araliaceae
-->Genus: Panax
-->Species: Panax ginseng
|
Pair Name | (20S)-Protopanaxatriol, EGFR-TKI | |||
Partner Name | EGFR-TKI | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Biological Phenomena | Induction-->Lipid accumulation | |||
Gene Regulation | Down-regulation | Phosphorylation | EGFR | hsa1956 |
Down-regulation | Expression | SCD | hsa6319 | |
In Vitro Model | HCC827 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_2063 |
PC-9 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_B260 | |
NCI-H1975 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_1511 | |
HCC827-GR-high1 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_S703 | |
In Vivo Model | Approximately 1×10⁷ H1975-luc cells were subcutaneously injected into the right hind limbs of mice. | |||
Result | Our findings uncover a link between lipid metabolic reprogramming and EGFR-TKI resistance, confirmed that combination target both EGFR and abnormal lipid metabolism maybe a promising therapy for EGFR-TKI resistance and highlighting the possibility of monitoring lipid accumulation in tumors for predicting drug resistance. |